Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads

Printer-friendly version
TitreIndolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads
Type de publicationJournal Article
Nouvelles publications2014
AuteursKaminska, KK, Bertrand HC, Tajima H, Stafford WC, Cheng Q, Chen W, Wells G, Arner ESJ, Chew E-H
JournalOncotarget
DOI10.18632/oncotarget.9579
Importer un fichierOncotarget
Unité de rattachement: 
UMR 7203